Mikhail Blagosklonny is an oncologist. He is also a professor who works at the Rosewell Park Cancer Institute of Buffalo in New York. Mikhail is actively involved in finding appropriate cancer therapies. Among his many pieces of research is that of the Rapamycin drug. Rapamycin is also called sirolimus and is a medication that is commonly used for the prevention of organ transplant rejection. It has also been used to manage a rare lung illness as well as to coat coronary stents. It is commonly known by its market name, Rapamune. Besides these uses, Rapamune is also used in cancer treatment.The drug was first isolated in 1972 from a bacterium that was found on Easter Island. At first, it was used as an anti-fungal and over time people realized of its many other benefits. People refer to it as the wonder drug, considering its high anti-proliferative and immunosuppressive properties. When scientists and doctors discovered its other incredible benefits, they abandoned its use as an anti-fungal.When Mikhail realized the many benefits that Rapamycin had, he recommended its use for cancer treatment. He reckons that the drug has a potential for increasing the lifespan of human beings. Blagosklonny’s contribution to the field of science is therefore immense. Some of the other diseases that Rapamycin is used to treat include:
- Hemolytic-uremic syndrome-the disease arises when a patient suffers from kidney failure, low platelet count, and anemia.
- Coronary stent coating-Rapamycin is used to coat coronary stents to prevent re-stenosis from reoccurring.
- Treatment of tuberous sclerosis-it is a congenital disorder that leads to tumor growth in several areas such as the kidneys, heart, and brain.
Mikhail Blagosklonny’s passion
Besides being a doctor, Mikhail is also a great philanthropist and a researcher. He has dedicated his life towards ensuring people from around the globe can access cancer treatment regardless of their economic status. Mikhail is inclined explicitly to studying both cancer and aging. He is interested in understanding how the two are related since cancer is more prevalent in older individuals than younger ones.Mikhail continues to carry out research that is relevant to the field of cancer. Considering how good he is at his job, He has managed to influence both his peers and students who would wish to assist him in the research later on. Cancer is among the most prevalent diseases around the globe today. Therefore, his research has attracted attention, especially within the medical field. It has ever been featured on impactjournals.com.Mr. Mikhail Blagosklonny main aim is to find not only the cure for cancer but also one that can treat the illness efficiently. He works towards developing a treatment option that is not too expensive or excruciating, like most of the cancer treatments on the market today. One of the ways he plans to do this is by finding a drug that can destroy cancerous cells without affecting healthy body cells. He understands that these cells will be vital in recovering the body and mind after several months or years of treatment.